Denali Therapeutics Inc.

DNLI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 9, 2026 FORM 4
144 Sep 4, 2026
4 Sep 4, 2026 FORM 4
4 Sep 3, 2026 FORM 4
144 Sep 2, 2026
144 Sep 1, 2026
4 Aug 14, 2026 FORM 4
4 Aug 13, 2026 FORM 4
144 Aug 11, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
SCHEDULE 13G/A Aug 4, 2026
8-K Jul 28, 2026 8-K
SCHEDULE 13G/A Jul 8, 2026
8-K Jun 18, 2026 8-K
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 4
8-K Jun 4, 2026 8-K
8-K May 22, 2026 8-K
← Newer Page 1 of 32 · 787 filings Older →